Cancer and Metastasis Reviews

, Volume 29, Issue 4, pp 737–750 | Cite as

Distant metastases do not metastasize

  • Dieter Hölzel
  • Renate Eckel
  • Rebecca T. Emeny
  • Jutta Engel
NON-THEMATIC REVIEW

Abstract

Distant metastases (MET) are for most solid cancers decisive life-threatening events. Data about MET-free survival and survival after MET show a strong dependency on the kind of cancer and the prognostic features. Nonetheless, within biological subgroups, the MET process is very homogenous. Therefore, the growth rate can be estimated from initiation of MET to MET diagnosis and to time of death. Based on the known volume doubling time of breast cancer, the time of the first possible dissemination can also be estimated. Important consequences of these MET-initiation estimates are the hypotheses that almost all MET are initiated before removal of the primary tumor and that MET do not metastasize in a clinically relevant magnitude. Although breast cancer data were primarily used to form these hypotheses, the discussed MET process can be generalized to all solid cancers. The impact of these hypotheses on diagnostic, curative and palliative treatment, aftercare, and especially on clinical research would be important.

Keywords

Breast cancer Metastasis Tumor growth Dissemination Survival 

Abbreviations

BC

Breast cancer

MET

(Distant) metastasization

pLN

(Positive) lymph node

PT

Primary tumor

TC(D)

Tumor cell (dissemination)

VD(T)

Volume doubling (time)

Notes

Acknowledgements

We thank the many doctors and clinicians who cooperate within the complex network of the Munich Cancer Registry despite the back-breaking medical bureaucracy for the daily health care. It is our duty to provide an adequate evaluation of the submitted data for outcomes, quality management and innovative treatments.

Conflict of interest

We declare that we have no conflicts of interest.

References

  1. 1.
    Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2(8), 563–572. doi: 10.1038/nrc865.CrossRefPubMedGoogle Scholar
  2. 2.
    Fidler, I. J. (2003). The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Reviews. Cancer, 3(6), 453–458. doi: 10.1038/nrc1098.CrossRefPubMedGoogle Scholar
  3. 3.
  4. 4.
    Curado, M., Edwards, B., Shin, H., Storm, H., Ferlay, J., Heanue, M., et al. (2007). Cancer incidence in five continents, vol. Ix. Lyon: IARC Scientific Publication No.160.Google Scholar
  5. 5.
    Nguyen, D. X., Bos, P. D., & Massague, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nature Reviews. Cancer, 9(4), 274–284. doi: 10.1038/nrc2622.CrossRefPubMedGoogle Scholar
  6. 6.
    Weinberg, R. (2007). The biology of cancer. New York: Garland Science.Google Scholar
  7. 7.
    Sugarbaker, E. V., Cohen, A. M., & Ketcham, A. S. (1971). Do metastases metastasize? Annals of Surgery, 174(2), 161–166.CrossRefPubMedGoogle Scholar
  8. 8.
    Tait, C. R., Dodwell, D., & Horgan, K. (2004). Do metastases metastasize? The Journal of Pathology, 203(1), 515–518. doi: 10.1002/path.1544.CrossRefPubMedGoogle Scholar
  9. 9.
    Sobin, L., Gospodarowicz, M., & Wittekind, C. (Eds.). (2009). Uicc: TNM classification of malignant tumors (7th ed.). Wiley-Blackwell: New York.Google Scholar
  10. 10.
    Leong, S. P., Cady, B., Jablons, D. M., Garcia-Aguilar, J., Reintgen, D., Jakub, J., et al. (2006). Clinical patterns of metastasis. Cancer and Metastasis Reviews, 25(2), 221–232. doi: 10.1007/s10555-006-8502-8.CrossRefPubMedGoogle Scholar
  11. 11.
    Sarfati, D., Blakely, T., & Pearce, N. (2010). Measuring cancer survival in populations: relative survival vs cancer-specific survival. International Journal of Epidemiology, 39(2), 598–610. doi: 10.1093/ije/dyp392.CrossRefPubMedGoogle Scholar
  12. 12.
    Benson, J. R., & della Rovere, G. Q. (2007). Management of the axilla in women with breast cancer. The Lancet Oncology, 8(4), 331–348. doi: 10.1016/S1470-2045(07)70103-1.CrossRefPubMedGoogle Scholar
  13. 13.
    Michaelson, J. S., Silverstein, M., Wyatt, J., Weber, G., Moore, R., Halpern, E., et al. (2002). Predicting the survival of patients with breast carcinoma using tumor size. Cancer, 95(4), 713–723. doi: 10.1002/cncr.10742.CrossRefPubMedGoogle Scholar
  14. 14.
    Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747–752. doi: 10.1038/35021093.CrossRefPubMedGoogle Scholar
  15. 15.
    Sotiriou, C., & Pusztai, L. (2009). Gene-expression signatures in breast cancer. The New England Journal of Medicine, 360(8), 790–800. doi: 10.1056/NEJMra0801289.CrossRefPubMedGoogle Scholar
  16. 16.
    Bernards, R., & Weinberg, R. A. (2002). A progression puzzle. Nature, 418(6900), 823. doi: 10.1038/418823a.CrossRefPubMedGoogle Scholar
  17. 17.
    Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., et al. (2006). Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clinical Cancer Research, 12(19), 5615–5621. doi: 10.1158/1078-0432.CCR-06-0169.CrossRefPubMedGoogle Scholar
  18. 18.
    Clarke, M. F., & Fuller, M. (2006). Stem cells and cancer: two faces of eve. Cell, 124(6), 1111–1115. doi: 10.1016/j.cell.2006.03.011.CrossRefPubMedGoogle Scholar
  19. 19.
    Chojniak, R., & Younes, R. N. (2003). Pulmonary metastases tumor doubling time: assessment by computed tomography. American Journal of Clinical Oncology, 26(4), 374–377. doi: 10.1097/01.COC.0000026481.38654.52.CrossRefPubMedGoogle Scholar
  20. 20.
    Finlay, I. G., Meek, D., Brunton, F., & McArdle, C. S. (1988). Growth rate of hepatic metastases in colorectal carcinoma. The British Journal of Surgery, 75(7), 641–644.CrossRefPubMedGoogle Scholar
  21. 21.
    Peer, P. G., van Dijck, J. A., Hendriks, J. H., Holland, R., & Verbeek, A. L. (1993). Age-dependent growth rate of primary breast cancer. Cancer, 71(11), 3547–3551.CrossRefPubMedGoogle Scholar
  22. 22.
    Kuroishi, T., Tominaga, S., Morimoto, T., Tashiro, H., Itoh, S., Watanabe, H., et al. (1990). Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Japanese Journal of Cancer Research, 81(5), 454–462.PubMedGoogle Scholar
  23. 23.
    Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: a systematic review. Lancet, 353(9159), 1119–1126. doi: S0140673699021431.CrossRefPubMedGoogle Scholar
  24. 24.
    Engel, J., Eckel, R., Kerr, J., Schmidt, M., Furstenberger, G., Richter, R., et al. (2003). The process of metastasisation for breast cancer. European Journal of Cancer, 39(12), 1794–1806. doi: S0959804903004222.CrossRefPubMedGoogle Scholar
  25. 25.
    Aguirre-Ghiso, J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews. Cancer, 7(11), 834–846. doi: 10.1038/nrc2256.CrossRefPubMedGoogle Scholar
  26. 26.
    Naumov, G. N., Folkman, J., Straume, O., & Akslen, L. A. (2008). Tumor-vascular interactions and tumor dormancy. APMIS, 116(7–8), 569–585. doi: 10.1111/j.1600-0463.2008.01213.x.CrossRefPubMedGoogle Scholar
  27. 27.
    Husemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell, 13(1), 58–68. doi: 10.1016/j.ccr.2007.12.003.CrossRefPubMedGoogle Scholar
  28. 28.
    Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., et al. (2004). Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research, 10(24), 8152–8162. doi: 10.1158/1078-0432.CCR-04-1110.CrossRefPubMedGoogle Scholar
  29. 29.
    Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine, 351(8), 781–791. doi: 10.1056/NEJMoa040766.CrossRefPubMedGoogle Scholar
  30. 30.
    Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., et al. (2008). Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. Journal of Clinical Oncology, 26(8), 1208–1215. doi: 10.1200/JCO.2007.13.6523.CrossRefPubMedGoogle Scholar
  31. 31.
    Townson, J. L., & Chambers, A. F. (2006). Dormancy of solitary metastatic cells. Cell Cycle, 5(16), 1744–1750. doi: 2864.PubMedGoogle Scholar
  32. 32.
    Wikman, H., Vessella, R., & Pantel, K. (2008). Cancer micrometastasis and tumour dormancy. APMIS, 116(7–8), 754–770. doi: 10.1111/j.1600-0463.2008.01033.x.CrossRefPubMedGoogle Scholar
  33. 33.
    Birkeland, S. A., & Storm, H. H. (2002). Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation, 74(10), 1409–1413. doi: 10.1097/01.TP.0000034717.19606.B5.CrossRefPubMedGoogle Scholar
  34. 34.
    Logan, P. T., Fernandes, B. F., Di Cesare, S., Marshall, J. C., Maloney, S. C., & Burnier, M. N., Jr. (2008). Single-cell tumor dormancy model of uveal melanoma. Clinical & Experimental Metastasis, 25(5), 509–516. doi: 10.1007/s10585-008-9158-2.CrossRefGoogle Scholar
  35. 35.
    Heyn, C., Ronald, J. A., Ramadan, S. S., Snir, J. A., Barry, A. M., MacKenzie, L. T., et al. (2006). In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magnetic Resonance in Medicine, 56(5), 1001–1010. doi: 10.1002/mrm.21029.CrossRefPubMedGoogle Scholar
  36. 36.
    Hölzel, D., Eckel, R., & Engel, J. (2009). [Colorectal cancer metastasis: frequency, prognosis, and consequences]. Chirurg, 80(4), 331–340. doi: 10.1007/s00104-008-1603-x.CrossRefPubMedGoogle Scholar
  37. 37.
    Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L., et al. (2009). Tumor self-seeding by circulating cancer cells. Cell, 139(7), 1315–1326. doi: 10.1016/j.cell.2009.11.025.CrossRefPubMedGoogle Scholar
  38. 38.
    Fisher, B., Anderson, S., Fisher, E. R., Redmond, C., Wickerham, D. L., Wolmark, N., et al. (1991). Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet, 338(8763), 327–331.CrossRefPubMedGoogle Scholar
  39. 39.
    Fisher, B., & Anderson, S. J. (2010). The breast cancer alternative hypothesis: is there evidence to justify replacing it? Journal of Clinical Oncology, 28(3), 366–374. doi: 10.1200/JCO.2009.26.8292.CrossRefPubMedGoogle Scholar
  40. 40.
    Chambers, A. F., Naumov, G. N., Vantyghem, S. A., & Tuck, A. B. (2000). Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Research, 2(6), 400–407.CrossRefPubMedGoogle Scholar
  41. 41.
    Glaves, D., Huben, R. P., & Weiss, L. (1988). Haematogenous dissemination of cells from human renal adenocarcinomas. British Journal of Cancer, 57(1), 32–35.PubMedGoogle Scholar
  42. 42.
    van de Vijver, M. J., He, Y. D., van’t Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. The New England Journal of Medicine, 347(25), 1999–2009. doi: 10.1056/NEJMoa021967.CrossRefPubMedGoogle Scholar
  43. 43.
    Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature, 459(7249), 1005–1009. doi: 10.1038/nature08021.CrossRefPubMedGoogle Scholar
  44. 44.
    Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., et al. (2007). The prognostic role of a gene signature from tumorigenic breast-cancer cells. The New England Journal of Medicine, 356(3), 217–226. doi: 10.1056/NEJMoa063994.CrossRefPubMedGoogle Scholar
  45. 45.
    Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3(6), 537–549. doi: S1535610803001326.CrossRefPubMedGoogle Scholar
  46. 46.
    Fisher, B. (1980). Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnofsky memorial lecture. Cancer Research, 40(11), 3863–3874.PubMedGoogle Scholar
  47. 47.
    Talmadge, J. E., Wolman, S. R., & Fidler, I. J. (1982). Evidence for the clonal origin of spontaneous metastases. Science, 217(4557), 361–363.CrossRefPubMedGoogle Scholar
  48. 48.
    Fidler, I. J. (1973). The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. European Journal of Cancer, 9(3), 223–227.PubMedGoogle Scholar
  49. 49.
    Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews. Cancer, 9(4), 302–312. doi: 10.1038/nrc2627.CrossRefPubMedGoogle Scholar
  50. 50.
    Pantel, K., & Brakenhoff, R. H. (2004). Dissecting the metastatic cascade. Nature Reviews. Cancer, 4(6), 448–456. doi: 10.1038/nrc1370.CrossRefPubMedGoogle Scholar
  51. 51.
    Palmieri, D., Chambers, A. F., Felding-Habermann, B., Huang, S., & Steeg, P. S. (2007). The biology of metastasis to a sanctuary site. Clinical Cancer Research, 13(6), 1656–1662. doi: 10.1158/1078-0432.CCR-06-2659.CrossRefPubMedGoogle Scholar
  52. 52.
    Mehta, M. P., Tsao, M. N., Whelan, T. J., Morris, D. E., Hayman, J. A., Flickinger, J. C., et al. (2005). The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics, 63(1), 37–46. doi: 10.1016/j.ijrobp.2005.05.023.PubMedGoogle Scholar
  53. 53.
    Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., et al. (2006). Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, 295(21), 2483–2491. doi: 10.1001/jama.295.21.2483.CrossRefPubMedGoogle Scholar
  54. 54.
    Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Natural Medicines, 1(2), 149–153.CrossRefGoogle Scholar
  55. 55.
    Steeg, P. S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Natural Medicines, 12(8), 895–904. doi: 10.1038/nm1469.CrossRefGoogle Scholar
  56. 56.
    Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC) Edinburgh (1987). Lancet, 2(8552), 171–175. doi:S0140-6736(87)90762-8.
  57. 57.
    de Boer, M., van Deurzen, C. H., van Dijck, J. A., Borm, G. F., van Diest, P. J., Adang, E. M., et al. (2009). Micrometastases or isolated tumor cells and the outcome of breast cancer. The New England Journal of Medicine, 361(7), 653–663. doi: 10.1056/NEJMoa0904832.CrossRefPubMedGoogle Scholar
  58. 58.
    Veronesi, U., Marubini, E., Mariani, L., Valagussa, P., & Zucali, R. (1999). The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. European Journal of Cancer, 35(9), 1320–1325. doi: S0959-8049(99)00133-1.CrossRefPubMedGoogle Scholar
  59. 59.
    Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., et al. (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. The New England Journal of Medicine, 347(16), 1233–1241. doi: 10.1056/NEJMoa022152.CrossRefPubMedGoogle Scholar
  60. 60.
    Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., et al. (2006). Sentinel-node biopsy or nodal observation in melanoma. The New England Journal of Medicine, 355(13), 1307–1317. doi: 10.1056/NEJMoa060992.CrossRefPubMedGoogle Scholar
  61. 61.
    Hartgrink, H. H., van de Velde, C. J., Putter, H., Bonenkamp, J. J., Klein Kranenbarg, E., Songun, I., et al. (2004). Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Journal of Clinical Oncology, 22(11), 2069–2077. doi: 10.1200/JCO.2004.08.026.CrossRefPubMedGoogle Scholar
  62. 62.
    Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., et al. (2004). Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg, 240(4), 644–657. doi: 00000658-200410000-00010. discussion 657–648.PubMedGoogle Scholar
  63. 63.
    Fisher, B., & Fisher, E. R. (1966). Transmigration of lymph nodes by tumor cells. Science, 152(727), 1397–1398.CrossRefPubMedGoogle Scholar
  64. 64.
    Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889), 699–702. doi: 10.1126/science.1154884.CrossRefPubMedGoogle Scholar
  65. 65.
    Zahl, P. H., Maehlen, J., & Welch, H. G. (2008). The natural history of invasive breast cancers detected by screening mammography. Archives of Internal Medicine, 168(21), 2311–2316. doi: 10.1001/archinte.168.21.2311.CrossRefPubMedGoogle Scholar
  66. 66.
    Chlebowski, R. T., Kuller, L. H., Prentice, R. L., Stefanick, M. L., Manson, J. E., Gass, M., et al. (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. The New England Journal of Medicine, 360(6), 573–587. doi: 10.1056/NEJMoa0807684.CrossRefPubMedGoogle Scholar
  67. 67.
    Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 1, 571–573.CrossRefGoogle Scholar
  68. 68.
    Naumov, G. N., Wilson, S. M., MacDonald, I. C., Schmidt, E. E., Morris, V. L., Groom, A. C., et al. (1999). Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. Journal of Cell Science, 112(Pt 12), 1835–1842.PubMedGoogle Scholar
  69. 69.
    Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E., Goldbrunner, R., Herms, J., et al. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nature Medicine, 16(1), 116–122. doi: 10.1038/nm.2072.CrossRefPubMedGoogle Scholar
  70. 70.
    Hoon, D. S., Kitago, M., Kim, J., Mori, T., Piris, A., Szyfelbein, K., et al. (2006). Molecular mechanisms of metastasis. Cancer and Metastasis Reviews, 25(2), 203–220. doi: 10.1007/s10555-006-8500-x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Dieter Hölzel
    • 1
  • Renate Eckel
    • 1
  • Rebecca T. Emeny
    • 1
  • Jutta Engel
    • 1
  1. 1.Munich Cancer Registry (MCR) of Munich Comprehensive Cancer CentreLudwigs-Maximilians-UniversityMunichGermany

Personalised recommendations